The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
101
297: VC turmoil, GLP-1 competition, & the war o...
Why are addiction treatments so hard to get?
27 min
102
296: Legal insider trading, booming biotech sto...
The dog days are ... over?
24 min
103
295: Humira’s legacy, CEO symbolism, and genomi...
What do CEOs owe the world?
34 min
104
294: Pharma goes to Washington, Alnylam's futur...
Has PhRMA lost its fangs?
30 min
105
293: AI in medicine, detangling hype, and Icela...
Introducing: the "futuristic silliness" beat
32 min
106
292: Vertex's polarizing data, Aduhelm's adieu,...
One last chatty about our favorite discussion topic
35 min
107
291: The plight of the VC, Gilead's latest setb...
And most importantly: what is Damian's Oscar pick for best picture?
31 min
108
290: Biotech layoffs, slumping stocks, and a 20...
What's going to move markets in 2024?
42 min
109
289: Live! From #JPM24
Meetings, parties, meetings on party buses, and more at #JPM24
28 min
110
287: 2023 in review, CEO report cards, and a lo...
Can you go to too many J.P. Morgan parties?
27 min
111
286: FTC v. biotech, Pfizer's kitchen sink, & V...
Is no one safe from the FTC?
34 min
112
285: CRISPR history, biotech struggles, & a big...
Just pretend a certain approval has already happened, thanks.
36 min
113
284: AbbVie’s big deal, CAR-T’s risks, & gettin...
Who’s to blame for failed trials?
28 min
114
283: A CRISPR milestone, algorithms amok, & bio...
What pairs well with a biotech downturn?
30 min
115
From Tradeoffs: Can the U.S. put an end to surp...
Most people agree that patients should be shielded from unexpected ambulance charges — but who will pick up the tab?
29 min
116
282: Lilly’s obesity drug, the power of radiati...
What does it mean to be Zepbound?
37 min
117
281: Decoding biotech hype, the Sarepta saga, &...
When is a failure not a failure?
32 min
118
280: ESMO highlights, Roivant's big deal, & bio...
Why are venture capitalists so optimistic?
29 min
119
279: Live from the 2023 STAT Summit
How do you pronounce “Bayer?”
33 min
120
278: Merger Mondays, Ozempic panic, & CRISPR'd ...
We discuss Bristol Myers Squibb’s multibillion-do…
32 min
121
277: Is the Nobel committee evolving? Plus, pre...
It’s Nobel week on the podcast, and reporter Mega…
31 min
122
276: Who discovered GLP-1? Plus: BrainStorm at ...
Our colleague Elaine Chen joins us to explain the…
34 min
123
275: A thorny ALS debate at the FDA, and the pr...
Our colleague Lizzy Lawrence joins us to explain …
33 min
124
274: Covid’s latest surge, Alnylam at the FDA, ...
Our colleague Helen Branswell joins us to discuss…
39 min
125
273: Back to school for biotech, Biogen's poten...
Josh Schimmer and Eric Schmidt, two longtime anal…
33 min